NR3C2 and hypertensive disorder: Aldosterone, a mineralocorticoid receptor (MR) agonist released by the adrenal cortex and acting in the distal nephron, is one of the main effectors of the volume expansion in hypertension [9] and a certain degree of non-suppressible and renin-independent aldosterone production is often present in patients with RHTN [10].